SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Winston Pharmaceuticals, Inc. Receives SBIR Grant from the National Institutes of Health (NIH) to Investigate Treatment for Postherpetic Neuralgia of the Trigeminal Nerve